Nivolumab exposure–response analysis for adjuvant treatment of melanoma supporting a change in posology

by Kinjal Sanghavi, Pradeep Vuppala, Vijay Ivaturi, Lora Hamuro, Amit Roy, Satyendra Suryawanshi
Published 2021-07-01

Immunogenicity in Clinical Practice and Drug Development: When is it Significant?

by Valentina Shakhnovich, Bernd Meibohm, Amy Rosenberg, Andrzej M. Kierzek, Rachel Hasenkamp, Ryan S. Funk, Craig J. Thalhauser, Piet H. van derGraaf, Yow‐Ming C. Wang, Lora Hamuro
Published 2020-03-01

A PCSK9-binding antibody that structurally mimics the EGF(A) domain of LDL-receptor reduces LDL cholesterol in vivo1[S]

by Yan G. Ni, Stefania Di Marco, Jon H. Condra, Laurence B. Peterson, Weirong Wang, Fubao Wang, Shilpa Pandit, Holly A. Hammond, Ray Rosa, Richard T. Cummings, Dana D. Wood, Xiaomei Liu, Matthew J. Bottomley, Xun Shen, Rose M. Cubbon, Sheng-ping Wang, Douglas G. Johns, Cinzia Volpari, Lora Hamuro, Jayne Chin, Lingyi Huang, Jing Zhang Zhao, Salvatore Vitelli, Peter Haytko, Douglas Wisniewski, Lyndon J. Mitnaul, Carl P. Sparrow, Brian Hubbard, Andrea Carfí, Ayesha Sitlani
Published 2011-01-01